Robert W. Dubois is the Interim President and CEO at the National Pharmaceutical Council (NPC). Read Bio
Paying for treatments or services that don’t offer real value for patients is a pervasive problem in the United States, with as much as $340 billion being spent on low-value or unnecessary care alone. With health care spending projected to reach nearly 20% of GDP in the next decade, eliminating low-value care and the associated costs to our health care system is becoming increasingly critical.
Building upon previous efforts aimed at reducing low-value care, partners of the Going Below The Surface Forum (GBTS) have developed a roadmap to guide health care stakeholders as they consider and implement low-value care interventions. The first in a series of webinars on the topic, this online learning event assisted in defining and understanding low-value care and its importance to various stakeholders.
At the conclusion of the session, participants will be able to:
- Describe the problem of low-value care, both clinically and economically.
- Understand the types of low-value care and what tests and treatments are associated with low-value care.
- Explore if low-value care occurs more often in low cost/high volume services or high cost/low volume services.
Watch Recorded Webinar
AcademyHealth and the National Pharmaceutical Council are proud to co-host this event as partners in Going Below The Surface, the sponsor of this series.